ObjectiveCycling is an important part of children's active travel, but its measurement using accelerometry is a challenge. The aim of the present study was to evaluate physical activity duration and intensity, and sensitivity and specificity of free-living cycling measured with a thigh-worn accelerometer.MethodsParticipants were 160 children (44 boys) aged 11.5 ± 0.9 years who wore a triaxial Fibion® accelerometer on right thigh for 8 days, 24 h per day, and reported start time and duration of all cycling, walking and car trips to a travel log. Linear mixed effects models were used to predict and compare Fibion-measured activity and moderate-to-vigorous activity duration, cycling duration and metabolic equivalents (METs) between the travel types. Sensitivity and specificity of cycling bouts during cycling trips as compared to walking and car trips was also evaluated.ResultsChildren reported a total of 1,049 cycling trips (mean 7.08 ± 4.58 trips per child), 379 walking trips (3.08 ± 2.81) and 716 car trips (4.79 ± 3.96). There was no difference in activity and moderate-to-vigorous activity duration (p> .105), a lower cycling duration (−1.83 min,p< .001), and a higher MET-level (0.95,p< .001) during walking trips as compared to cycling trips. Both activity (−4.54 min,p< .001), moderate-to-vigorous activity (−3.60 min,p< .001), cycling duration (−1.74 min,p< .001) and MET-level (−0.99,p< .001) were lower during car trips as compared to cycling trips. Fibion showed the sensitivity of 72.2% and specificity of 81.9% for measuring cycling activity type during the reported cycling trips as compared to walking and car trips when the minimum required duration for cycling was less than 29 s.ConclusionsThe thigh-worn Fibion® accelerometer measured a greater duration of cycling, a lower MET-level, and a similar duration of total activity and moderate-to-vigorous activity during free-living cycling trips as compared to walking trips, suggesting it can be used to measure free-living cycling activity and moderate-to-vigorous activity duration in 10–12-year-old children.